Repository logo
 
No Thumbnail Available
Publication

Synthesis of novel 1-aryl-3-[2,3- or 4-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas and evaluation as VEGFR2 tyrosine kinase inhibitors

Use this identifier to reference this record.
Name:Description:Size:Format: 
Poster Int. 74-cópia 2.pdf749.74 KBAdobe PDF Download

Advisor(s)

Abstract(s)

Vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase is involved in cancer and in angiogenesis. Herein, we report the synthesis of novel1-aryl-3-[2-, 3- or 4-{thieno[3,2-b ]pyridin-7-ylthio) phenyl]ureas as VEGFR2 inhibitors by promoting the regioselective attack of the thiol group of the 4-aminothiophenol in the chlorine nucleophilic displacement on 7-chlorothieno[3,2-b]pyridine 1, obtaining the aminated compounds Za- c. These were reacted with arylisocyanates to give the corresponding 1,3-diarylureas 3a-c, 4a-c and Sa-c (see scheme).

Description

Keywords

Citation

Peixoto, Daniela; Queiroz, Maria João; Abreu, Rui M.V.; Froufe, Hugo; Calhelha, Ricardo C.; Ferreira, Isabel C.F.R. (2012). Synthesis of novel 1-aryl-3-[2,3- or 4-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas and evaluation as VEGFR2 tyrosine kinase inhibitors. In XXIInd International Symposium on Medicinal Chemistry. Berlin

Research Projects

Organizational Units

Journal Issue